Nov. 24 2025
Source Page: Cardiovascular risk assessment and lipid modificationAug. 13 2025
Source Page: Specialised neurology services (adults)Aug. 13 2025
Source Page: Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and overAug. 13 2025
Source Page: Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and overAug. 13 2025
Source Page: Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and overAug. 13 2025
Source Page: Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and overAug. 13 2025
Source Page: Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and overAug. 13 2025
Source Page: Sacituzumab govitecan for treating hormone receptor-positive HER2-negative metastatic breast cancer after 2 or more treatments (terminated appraisal)Aug. 13 2025
Source Page: Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and overAug. 12 2025
Source Page: Graduation guarantee for newly qualified nurses and midwives